Table 3.
Biomarker Findings of the Study Population
| Variables | HCC (N=30)p1 | Non-HCC Patients (Chronic Hepatitis and Cirrhosis) (N=30)p2 | Control (N=30)p3 | p-value |
|---|---|---|---|---|
| AFP | ||||
| Mean±SD | 1085.2±1465.4a,b | 22±19.6a,c | 1.24±0.38 | <0.001 |
| Median (IQR) | 536.5 (8−4840) | 21 (2.6–87) | 1.1 (0.9−1.9) | |
| GP73 | ||||
| Mean±SD | 11.1±8.5a,b | 4.4±2.9a,c | 1.4±1.6 | <0.001 |
| Median (IQR) | 8.9 (0.88−33) | 3.3 (1.9−12.9) | 0.6 (0.19−5.6) |
Notes: Data are presented as mean±SD (standard deviation) or median (range). ap1 versus p2 <0.05; bp1 versus p3 <0.05; cp2 versus p3 <0.05.
Abbreviations:- AFP, alpha-fetoprotein; GP73, Golgi protein 73.